Antibody Drug Conjugate News and Research

RSS
ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

First quad-channel, 16-bit ADC for medical imaging applications

First quad-channel, 16-bit ADC for medical imaging applications

Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011

Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Seattle enters second ADC research collaboration agreement with Genmab

Seattle enters second ADC research collaboration agreement with Genmab

United Imaging Healthcare launches new 48-channel portable ultrasound machine

United Imaging Healthcare launches new 48-channel portable ultrasound machine

Seattle Genetics presents SGN-35 study data in Hodgkin lymphoma at EBMT meeting

Seattle Genetics presents SGN-35 study data in Hodgkin lymphoma at EBMT meeting

SGEN, Abbott enter collaboration agreement for ADC products

SGEN, Abbott enter collaboration agreement for ADC products

Millennium, SGEN expand ADC collaboration

Millennium, SGEN expand ADC collaboration

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

ADC announces RNAscope technology clinical study results for HPV-associated head and neck cancers

ADC announces RNAscope technology clinical study results for HPV-associated head and neck cancers

Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma

Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma

Life Technologies introduces new Asia distribution hub in Singapore

Life Technologies introduces new Asia distribution hub in Singapore

Positive preliminary data from ongoing PSMA ADC phase 1 study against prostate cancer

Positive preliminary data from ongoing PSMA ADC phase 1 study against prostate cancer

Sanofi-aventis acquires world-wide license for ADC products

Sanofi-aventis acquires world-wide license for ADC products

Spirogen, Genentech enter multi-year ADC research collaboration and license agreement

Spirogen, Genentech enter multi-year ADC research collaboration and license agreement

Seattle Genetics enters ADC collaboration agreement with Pfizer

Seattle Genetics enters ADC collaboration agreement with Pfizer

Immunomedics announces additional claim for RS7 antibodies patent family

Immunomedics announces additional claim for RS7 antibodies patent family

SunTech Medical, ADC launch ADView spot-check device

SunTech Medical, ADC launch ADView spot-check device

Immunomedics reports CD22 antibody produced significant anti-tumor response

Immunomedics reports CD22 antibody produced significant anti-tumor response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.